# Assessment of the Evolution of Wound Biomarkers in Venous Leg Ulcers Treated With KLOX Biophotonic System

> **NCT03593369** · NA · UNKNOWN · sponsor: **KLOX Technologies Inc.** · enrollment: 25 (estimated)

## Conditions studied

- Venous Leg Ulcer

## Interventions

- **DEVICE:** KLOX BioPhotonic System (single treatment)+SOC
- **DEVICE:** KLOX BioPhotonic System (consecutive treatments)+SOC
- **OTHER:** Standard of Care (SOC)

## Key facts

- **NCT ID:** NCT03593369
- **Lead sponsor:** KLOX Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-09
- **Primary completion:** 2020-03
- **Final completion:** 2020-06
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03593369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03593369, "Assessment of the Evolution of Wound Biomarkers in Venous Leg Ulcers Treated With KLOX Biophotonic System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03593369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*